Globus Medical (NYSE:GMED – Get Free Report)‘s stock had its “hold” rating restated by equities researchers at Needham & ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Nevro Corp (NVRO – Research Report), Globus ...
HighTower Advisors LLC raised its stake in Globus Medical, Inc. (NYSE:GMED – Free Report) by 2.4% during the fourth quarter, ...
6d
Zacks.com on MSNShould You Hold Globus Medical Stock in Your Portfolio Now?Globus Medical, Inc. GMED continues to benefit from the robust demand for its Musculoskeletal Solutions products. Following the NuVasive merger, the combined company has formed a global ...
According to Benzinga Pro, Globus Medical's peer group average for short interest as a percentage of float is 4.18%, which means the company has less short interest than most of its peers. Did you ...
Globus Medical, Inc. GMED continues to benefit from the robust demand for its Musculoskeletal Solutions products. Following the NuVasive merger, the combined company has formed a global ...
4h
Daily Post Nigeria on MSNN25.3bn Debt: Nigerian court orders take over of Bacita Sugar company’A Nigerian Federal High Court has ordered Keystone Bank to take over Bacita Sugar Company over failure to clear an outstanding N25.5 billion debt. The ...
Justice Hauwa Buhari who granted the exparte order also ordered the banks to depose to a verifying affidavit confirming compliance with the Order.
4d
Zacks Investment Research on MSNGMED Stock Jumps 41.8% in a Year: What's Behind the Rally?Globus Medical GMED has experienced strong upward momentum in the past year, with its shares rising 41.8%. This has far outpaced the industry’s 7.5% decline and the S&P 500 composite’s 8.8% growth.
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But ...
Barclays analyst Matt Miksic maintained a Buy rating on Alphatec Holdings (ATEC – Research Report) today and set a price target of $21.00. The ...
Labcorp lists the plant as part of its consumer genetics business and plans to begin eliminating positions in May.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results